Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	32.17	-154.34	-227.55
Graham Fair Price	41.49	0.10	0.07
PEG	-83.49	-0.51	3.09
Price/Book	32.08	6.29	4.76
Price/Cash Flow	-20.92	1506.63	-1905.27
Prices/Earnings	33.96	-51.02	-77.26
Price/Sales	-33.96	18.83	28.52
Price/FCF	-20.92	1506.63	-1905.27
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.30	0.30
Operating Margin	-20.82	-0.14	-0.12
ROA	-100.00	-0.02	-0.01
ROE	-0.02	-0.03	-100.00
ROIC	-0.02	-0.04	-140.71
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.10	0.12	-17.15
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.34	-1.42	322.02
EPS QOQ	0.25	-1.00	300.00
FCF QOQ	0.98	2.67	172.52
Revenue QOQ	-0.66	1.00	51.65
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	441.91	220.95	-50.00
Days Sales Outstanding (DSO)	51.05	27.41	-46.30
Inventory Turnover	0.20	0.41	100.00
Debt/Capitalization	0.04	0.04	9.37
Quick Ratio	2.12	2.14	1.08
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.12	0.12	0.05
Cash	0.07	0.07	0.05
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	67.11
Revenue	0.02	0.04	100.10
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	4.24	4.24	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	27.12	13.42	-50.52
Naive Interpretation	Member

06 - Financial Health · Bad

Rating